Thursday, November 5, 2026

The Bank of Princeton And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

The Bank of Princeton And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

2. The Bank of Princeton

24.2% sales growth and 6.82% return on equity

The Bank of Princeton provides various banking products and services.

The Bank of Princeton's sales growth this year is expected to be 14% and a negative 0.8% for next year.

Year-on-year quarterly revenue growth grew by 18%, now sitting on 48.43M for the twelve trailing months.

The Bank of Princeton's sales growth for the next quarter is 24.2%. The company's growth estimates for the current quarter and the next is 54.5% and 28.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.82%.

Volatility

The Bank of Princeton's last day, last week, and last month's current volatility was 2.14%, 1.08%, and 1.51%, respectively.

The Bank of Princeton's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.40% (day), 1.77% (last week), and 2.88% (last month), respectively.

The Bank of Princeton's Stock Yearly Top and Bottom Value

The Bank of Princeton's stock is valued at $27.12 at 17:22 EST, under its 52-week high of $30.00 and way above its 52-week low of $17.40.

The Bank of Princeton's Moving Average

The Bank of Princeton's worth is under its 50-day moving average of $27.95 and way higher than its 200-day moving average of $23.94.

3. Rogers Corporation

12.4% sales growth and 5.11% return on equity

Rogers Corporation designs, develops, manufactures, and sells engineered materials and components worldwide.

Rogers Corporation's sales growth this year is expected to be 12.2% and 8.7% for next year.

Year-on-year quarterly revenue growth grew by 8.7%, now sitting on 802.58M for the twelve trailing months.

Rogers Corporation's sales growth for the next quarter is 12.4%. The company's growth estimates for the current quarter and the next is 94.6% and 59.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.11%.

Volatility

Rogers Corporation's last day, last week, and last month's current volatility was 2.88%, 1.45%, and 2.09%, respectively.

Rogers Corporation's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.38% (day), 2.94% (last week), and 3.76% (last month), respectively.

Rogers Corporation's Stock Yearly Top and Bottom Value

Rogers Corporation's stock is valued at $189.71 at 17:22 EST, below its 52-week high of $199.50 and way higher than its 52-week low of $92.01.

Rogers Corporation's Moving Average

Rogers Corporation's worth is above its 50-day moving average of $187.20 and way higher than its 200-day moving average of $152.53.

4. Gentherm Inc

90.2% sales growth and 11.15% return on equity

Gentherm Incorporated designs, develops, manufactures, and markets thermal management technologies.

Gentherm Inc's sales growth this year is expected to be 19.7% and 7.6% for next year.

Year-on-year quarterly revenue growth grew by 25.4%, now sitting on 913.1M for the twelve trailing months.

Gentherm Inc's sales growth for the next quarter is 90.2%. The company's growth estimates for the ongoing quarter and the next is 27.5% and 350%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.15%.

Volatility

Gentherm Inc's last day, last week, and last month's current volatility was 2.17%, 1.58%, and 2.40%, respectively.

Gentherm Inc's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.25% (day), 3.16% (last week), and 4.13% (last month), respectively.

Gentherm Inc's Stock Yearly Top and Bottom Value

Gentherm Inc's stock is valued at $76.30 at 17:22 EST, under its 52-week high of $81.98 and way higher than its 52-week low of $32.70.

Gentherm Inc's Moving Average

Gentherm Inc's value is above its 50-day moving average of $74.61 and way higher than its 200-day moving average of $61.55.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,549 source documents archived
Query this data → isubstrate.com
The Bank of Princeton And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity | Via News